NARCAN
Pronunciation: nal-OX-oen (NAR-kan)


What it isNaloxone 4 mg nasal spray (NARCAN, 2015; OTC since 2023) is a mu-opioid antagonist for community reversal of opioid overdose.
Why this oneA ready-to-use, needle-free device lets bystanders restore breathing before emergency clinicians arrive.
What limits itIt precipitates abrupt withdrawal in opioid-dependent people, and its intranasal half-life ~2 h may be shorter than the opioid's; repeat dosing and emergency care remain essential.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Emergency treatment of known or suspected opioid overdose | Adults and pediatric patients | 4 mg (1 spray) intranasally in one nostril | repeat every 2–3 minutes in alternating nostrils until response | No stated maximum — continue until patient responds or emergency help arrives |
Renal Undefined
Hepatic Undefined
Repeat every 2–3 minutes until the person responds or emergency help arrives
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | brand $/unit | CostPlus | |
|---|---|---|---|---|---|
| 4 mg/spray | nasal spray | per unit | $17.18/ea | — | offered |
| 8 mg/spray | nasal spray | per unit | — | $59.77/ea | not offered |
| 3 mg/spray | nasal spray | per unit | — | not offered |
Other forms: Naloxone
Available combined with: Buprenorphine/ naloxone (SUBOXONE)
⚠ BOXED WARNINGS
Open Naloxone nasal spray in the interactive console ↗
